Sign in

CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Rapport Therapeutics, Inc.

Sign in to watch
Ticker
RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880724208
Phone
857-321-8020
Business address
99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
Former names
Rapport Therapeutics, Inc.
  1. 4 Grant or award Director acquired 1,428,571 shares (grant or award)
  2. 4 Open-market buy Director bought 969,480 shares at $21.00 ($20,359,080)
  3. 4 Planned sale Chief Executive Officer sold 2,210 shares at $29.16 ($64,448)
  4. 4 Open-market buy Director bought 3,600 shares at $27.35 ($98,478)
  5. 4 Open-market buy Director bought 3,680 shares at $27.08 ($99,636)
  6. 4 Open-market buy Director bought 3,789 shares at $26.39 ($99,992)
  7. 4 Open-market buy Director bought 35,714 shares at $27.28 ($974,278)
  8. 4 Open-market buy Director bought 9,411 shares at an average $26.45 ($248,891)
  9. 4 Open-market buy Chief Financial Officer bought 5,500 shares at $26.10 ($143,550)
  10. 4 Planned sale Chief Executive Officer sold 4,522 shares at an average $31.68 ($143,273)
  11. 4 Planned sale Chief Operating Officer sold 10,000 shares at an average $33.19 ($331,856)
  12. 4 Planned sale Chief Executive Officer sold 2,210 shares at an average $39.17 ($86,565)
  13. 4 Planned sale Chief Executive Officer sold 8,210 shares at an average $45.61 ($374,498)
  14. 4 Planned sale Chief Executive Officer sold 18,921 shares at $49.57 ($937,957)
  15. 4 Planned sale Chief Development Officer sold 50,160 shares at an average $50.47 ($2,531,582)
  16. 4 Planned sale Chief Development Officer sold 404 shares at $49.90 ($20,160)
  17. 4 Planned sale Chief Executive Officer sold 51,499 shares at an average $47.25 ($2,433,176)
  18. 4 Planned sale Chief Executive Officer sold 2,210 shares at an average $42.11 ($93,061)
  19. 4 Planned sale Chief Executive Officer sold 8,210 shares at an average $40.00 ($328,437)
  20. 4 Planned sale Chief Operating Officer sold 10,000 shares at an average $41.58 ($415,798)

Page 1 of 6 · 120 filings